PubMed Health⌕ Search

Biomedical subjects

C J Holloway

Publications and source records attributed to C J Holloway.

16 recordsLinked to original sources

Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor.

Lenograstim has been developed by recombinant DNA technology and is expressed in large-scale mammalian cell culture. It has been shown that lenograstim is indistinguishable in its physicochemical, structural and biological properties with respect to native granulocyte colony stimulating factor isolated from a human cell line. In particular, both the recombinant and natural proteins have identical amino acid sequences, contain the same intra-polypeptide chain disulphide bridges and exhibit the same posttranslational carbohydrate structures. Lenograstim is manufactured by expanding inoculum from vials of the Manufacturer's Working Cell Bank (from molecular cloning) followed by culture in a large bioreactor. Purification of lenograstim involves a four-step chromatographic process. The active ingredient is monitored by in-process controls at all stages of manufacture and routinely as purified bulk. The finished product is formulated into excipients reflecting conditions close to the natural environment of the protein with respect to pH, osmolarity and the presence of human serum albumin.

Amino Acid Sequence↗

Mechanism of sulphate transfer from 4-nitrophenylsulphate to phenolic acceptors via liver cytosolic sulphotransferase.

Phenol sulphotransferase from cat and rabbit liver cytosol has been investigated using 4-nitrophenylsulphate as primary sulphate donor. The first stage of the reaction involves sulphation of cofactor adenosine 3',5'-diphosphate to adenosine 3'-phosphate 5'-phosphosulphate, which in turn acts as sulphate donor for other phenolic acceptors. Adenosine 3',5'-diphosphate is regenerated in this second stage, so that the overall reaction is a sulphate transfer from 4-nitrophenylsulphate to the phenolic acceptor. High acceptor concentrations lead to inhibition of the reaction; very low concentrations give deviation from Michaelis-Menten kinetics. From the kinetic data, a mechanism is suggested in which an enzyme-adenosine 3'-phosphate 5'-phosphosulphate complex is formed in situ, with which the acceptor then interacts to give the final sulphate transfer. The system employed here is useful for the study of phenol sulphotransferase in view of the difficulty in obtaining adequate amounts of adenosine 3'-phosphate 5'-phosphosulphate from commercial sources.

Animals↗

Hepatotoxic effects of sera from patients with fulminant hepatitis B on isolated rat hepatocytes in culture.

The hepatotoxicity of sera from patients with terminal fulminant hepatic failure has been investigated by cell culture techniques. It could be shown that both untreated and heat-treated sera are cytotoxic in nature. Compared with the action of sera from healthy individuals on liver cells in primary monolayer culture, the pathological sera exhibited significantly different behaviour with respect to morphological and biochemical parameters such as cell adhesion, growth and proliferation, and enzyme release.

Alanine Transaminase↗

Properties of agarose-encapsulated adsorbents. II. Elimination of endogenous and exogenous phenolic compounds from human serum.

Phenolic compounds derived from the amino acid tyrosine are endogenous toxins, which are believed to be involved in the pathogenesis of hepatic coma. There are also xenobiotic phenolic substances, such as p-hydroxy-acetanilide (paracetamol or acetaminophen), which can lead to serious complications if taken in an overdose. In both cases, a drastic therapeutic measure such as haemoperfusion may be indicated to eliminate the toxin from the blood. In the present work, human serum has been dosed with the phenolic compounds of immediate relevance in exogenous and endogenous intoxication, and the effectiveness of various adsorbent materials for the elimination of the toxins from the serum has been investigated. Resins and charcoal in the native state have been compared with those encapsulated into large agarose beads, a process which improves the haemocompatibility and thus the practicability of the adsorbents. A certain degree of specificity has been observed. Whereas phenolic acids are adsorbed quite effectively onto the strongly basic ion exchange resins of the Dowex 1X type, particularly 1X8 or 2X8, phenol or paracetamol are less effectively eliminated. In contrast to many other classes of toxin, the Amberlite XAD-type resins are ineffective for all the phenolic substances investigated. Charcoal is the most effective adsorber in most cases, particularly when encapsulated in powder form into agarose beads.

Absorption↗

Properties of agarose-encapsulated adsorbents. I. Adsorption of digoxin from human serum.

The elimination of the cardioactive steroid, digoxin, from human serum by a range of adsorbent phases has been investigated. In the native state, the uncharged resins of the Amberlite XAD-type proved more effective than the ion-exchange resins, Dowex 1X, or active charcoal. Of the materials tested, Amberlite XAD-8 is by far the best suited resin for haemoperfusion in cases of digoxin overdose, whereby the less efficient XAD-4 is more commonly employed at present in clinics. In order to improve the haemocompatibility of the adsorbent materials, the technique of encapsulation into large agarose beads has been employed. In contrast to the effects observed with many other classes of xenobiotics, encapsulation into agarose beads results in a considerable loss of adsorptive capacity of digoxin by Amberlite XAD-8. The poor performance of active charcoal in form of granules can be improved by an order-of-magnitude using charcoal powder encapsulated in agarose. Thus, the latter material, or uncoated XAD-8 resin should be considered as a better alternative to materials in current use for extracorporeal detoxification in cases of digoxin overdose.

Anion Exchange Resins↗

Gas chromatographic method for the quantitative assay of alkane thiol S-methyltransferase.

A method is described for the quantitative assay of the methylation of alkane-thiols from the methyl-donor S-adenosylmethionine, catalysed by the microsomal enzyme S-adenosyl-L-methionine:thiol S-methyltransferase (E.C. 2.1.1.9). The reaction is carried out in sealed vials, one fifth of whose volume is taken up by an aqueous phase containing the enzyme and reactants. The volatile substrates and products of the reaction, thiols and thioethers, respectively, are present in equilibrium both in the liquid and gas phases in the reaction vessels. Aliquots of the gas phase are removed at intervals in gas-tight syringes, and analysis is performed directly on a gas chromatograph fitted with a flame-ionization detector. The amounts of thiol and thioether detected are then related to the total amounts of substance in the reaction vessels from calibration measurements, so that the kinetics of the enzymatic process can be evaluated. This technique offers distinct advantages over previously reported methods, in that no radioactively labelled compounds are required. Furthermore, decreases in substrate and increases in product can be assayed simultaneously, and the methylation of a mixture of thiols can be monitored in a single set of analyses.

Chromatography, Gas↗

The capillary-isotachophoretic analysis of reactants and products of glucuronidation. A new method for the assay of UDPGlucuronosyltransferase.

UDPglucuronosyltransferase competes with a nucleotide pyrophosphatase for UDPglucuronate as a substrate. Both enzyme systems are located in the microsomal fraction of mammalian liver homogenates, and the pyrophosphatase is present in all but the purest preparations of UDP-glucuronosyltransferase, since solubilisation procedures yield both activities in the 100 000 x g supernatant. In glucuronidation studies, it is important to be able to ascertain the degree of hydrolysis of the substrate UDPglucuronate due to the pyrophosphatase activity. A new method is reported using analytical capillary isotachophoresis whereby reactants and products of both glucuronidation and hydrolysis can be assayed simultaneously. The example presented in this paper is the glucuronidation of paracetamol (4-acetamidophenol) an important phenolic drug of toxicological interest. Rabbit liver microsomes glucuronidate this substance much more slowly than other phenolic compounds, so that hydrolysis of the donor molecule UDPglucuronic acid becomes of primary importance. Furthermore, the ionic mobility of 4-acetamidophenyl glucuronoside is much less than the other constitutents of assay mixtures under the analytical conditions employed, so that a well-defined separation from other reaction species is afforded.

Acetaminophen↗

Thiols and hepatic coma.

The plasma concentrations of methane and ethane thiols have been determined during the course of acute liver failure by a gas-chromatographic technique, and a prognostic evaluation is possible using this analysis. Further, the effects of some therapeutic measures, notably hemoperfusion, on the thiol levels have been investigated. It is concluded that these toxins, which are to a large extent covalently protein-bound, are extremely difficult to remove in an extracorporeal liver support system. Since the cause of the pathological thiol concentrations is probably the elevated plasma methionine levels associated with severe liver disease, it is suggested that the most hopeful course of action against the accumulation of thiols in the body might be a preventative therapy involving the normalization of methionine at an early stage of the disease.

Charcoal↗

The application of immobilized enzymes in an artificial liver support system.

A novel method of extracorporeal support for fulminant liver failure is reported whereby the most important detoxification processes of the liver are reproduced in an enzyme reactor. Most of the endogenous toxins involved in hepatic coma can be deactivated directly by conjugation with a hydrophilic residue such as glucuronic acid or glutathione, or by the neutralization of active groups through structural modification by methyl transfer. The enzymes responsible for these processes have been isolated and purified from rabbit liver, and covalently bound onto a hemocompatible form of agarose matrix. This system has been shown to be capable of catalyzing the desired reactions with endogenous toxins such as phenols and mercaptans in vitro, and phenols in rabbits in vivo.

Acetaminophen↗

Enzymatic methylation of alkane thiols.

A membrane-bound enzymatic activity has been found in rabbit liver microsomes, which catalyses the transmethylation from S-adenosylmethionine to a series of C1-C3 alkane thiols. Methane and ethane thiols are known to be endogenous toxins, which may play an important role in the pathogenesis of hepatic coma, and methylation could provide an important pathway for the metabolic 'detoxification' of this class of compounds through neutralisation of the highly reactive sulph-hydryl group.

Animals↗

Large agarose beads for extracorporeal detoxification systems. Preparation and enzymatic properties of agarose-bound UDP-glucuronyltransferase.

UDP-glucuronlytransferase, E.C. 2.4.1.17, has been solubilised from the microsomal fraction of liver homogenate from phenobarbital pretreated rabbits by lipase or detergent treatments. A 110-fold purification of the enzyme with respect to the crude homogenate was achieved by precipitation and column separations. The cholate-detergent solubilised enzyme was far more stable than that prepared by the lipase method. The partially purified UDP-glucuronyltransferase has been covalently bound to cyanogen bromide-activated agarose in the form of large haemocompatible beads to the extent of 0.22 mg protein per mg agarose dryweight, equivalent to about 25 mg of swollen gel. The acceptors for glucuronidation employed were the non-physiological phenolic compounds p-nitrophenol and 1-naphthol, and an exogenous and endogenous substance of physiological importance, namely paracetamol and phenol respectively. The immobilised enzyme exhibited at least 80% of the original activity of the solubilised enzyme, and the catalytic function was preserved for a much longer period of time in the carrier-bound form. The system described in this publication could well be applied in an extracorporeal liver assist device for the replacement of glucuronidation function.

Animals↗

The removal of hypnotic drugs from human serum. A comparative investigation of the adsorptive properties of native and agarose-encapsulated resins and charcoal.

The adsorptive capacities of some ion-exchange resins and activated charcoal towards the hypnotic drugs, phenobarbital, glutethimide, carbromal, and methaqualone, have been investigated. Furthermore, the properties of some of these resins and charcoal, encapsulated in an agarose matrix in the form of beads, have been compared with those of the adsorbent phases in their native states. In general, the adsorptive capacities of charcoal were at least as good as, and frequently better than those of the resins. Amberlite XAD-type resins had a higher affinity than Dowex-type resins for all the drugs tested, except for phenobarbital, which was not adsorbed to a satisfactory extent onto Amberlite XAD-4. The encapsulation of adsorbent phases into agarose beads of diameter 5-10 mm results in a reduction of the adsorbtion of the drugs. Nonetheless, the remaining adsorptive capacity is sufficient for application in an extracorporeal detoxification system. Moreover, the overwhelming advantage of good haemocompatibility is provided by the agarose-encapsulated adsorbents.

Adsorption↗

Agarose-encapsulated adsorbents.

A method is described for the encapsulation of ion-exchange and adsorbent resins of native particle diameter 0.2-1.0 mm into agarose spheres of diameter 5-10 mm. Plasma components diffuse rapidly through the agarose coating, but blood corpuscles have no direct access to the resins. At least 0.3 g of resin can be incorporated into 1 g of the agarose beads, so that the effective surface area with regard to erythrocytes, thrombocytes, and leucocytes is reduced by a factor of at least 5, and up to 20, depending on the native resin particle size. Pulverised active charcoal, or resins in powder form can also be encapsulated in this manner. The haemocompatibility of the agarose coating seems to be considerably more acceptable than that of the adsorbents in their native state.

Adsorption↗

Large agarose beads for extracorporeal detoxification systems.

A method is reported by which agarose beads of diameter 1000 to 10000 microns can be prepared from Sepharose (R) 4B (native bead diameter 40 to 190 microns). Haemoperfusion experiments indicate that the enlarged beads are relatively haemocompatible; platelet loss is considerably less than that reported for many other bio-materials employed in haemoperfusion, and haemolysis is slight even after perfusion for several hours at flow-rates in excess of 25 ml/min. The beads can be activated by cyanogen bromide for the immobilisation of proteins. The sites for protein fixation are not restricted to the outside surface of the beads; small water soluble molecules, and serum proteins diffuse quite rapidly through the enlarged beads. A possible medical application of the large beads is in extracorporeal detoxification by chromatographic extraction or enzymatic modification, particularly of lipophilic toxins, using the enlarged beads as a carrier-matrix. The results described in this publication prove the viability of this concept. Such methods should be especially useful as artificial supports in fulminant hepatic failure.

Acetaminophen↗